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INTRODUCTION
●
●

●

●

Breast cancer → second leading cause of cancer death in
women
Triple negative breast cancer (TNBC) (Hossain et al., 2018)
○ Aggressive subclass deﬁned by lack of hormonal
receptors and HER2 ampliﬁcation
○ Accounts for 15% of all invasive breast cancers
Patients:
○ Have limited therapeutic options
○ Are prone to earlier recurrence and local/distant
metastasis
○ <15% relative 5-year survival rate (Gordon et al.,
2021)
JAGGED-1 (JAG1) (Reedijk et al., 2005)
○ Notch ligand
○ Correlates with metastatic status and poor survival
in clinical data
○ Exact mechanism in which JAG1 increases
metastasis is unknown

We hypothesize that JAG1 increases
TNBC metastasis by promoting cancer
cell extravasation through the
endothelial barrier.
HYPOTHESIS
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Used TMA and western blot
Generated JAG1-knockout cells using
CRISPR/Cas9 technologies
Modeled the extravasation of JAG1-knockout
cells to JAG1-positive cells
Interrogated lung capillary extravasation
○ Chosen due to propensity of TNBC cells
to invade the lung
“Rescued” JAG1 expression in knockout cells
using lentiviral (LV) mediated transduction
3 Groups
○ Group 1: Untreated
MDA-MB-231-D3H2LN (D3-Parental)
○ Group 2: D3H2LN JAG1KO Clone 1 (RFPLV)
○ Group 3: D3H2LN JAG1KO Clone 1-JAG1LV
(JAG1LV)
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Figure 1: JAG1 May Promote Aggressive Metastatic Behavior in Breast Cancer
A

B

C

D

Figure 1. (A) Breast cancer tissue microarray (TMA) containing 12
cases of paired normal and primary, and 36 cases of primary and
metastatic tumors (LNs) with JAG1 staining shown in green. Analysis
of the TMA reveals that (B) JAG1 is higher in the primary tumor of
patients with positive LNs and (C) metastatic LN samples have higher
JAG1 compared to matched primary samples. (D) Western blot of
human and murine TNBC lines probing for JAG1 expression.
Subsequent results focuses mainly on MDA-MB-231-D3H2LN
(D3H2LN), which is highly metastatic to LNs and lung.

Figure 2: Generation of Five Knockout JAG1 Cell Lines Using CRISPR/Cas9
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Figure 2. (A) Two separate guide RNAs (sgRNAs) targeting Exon2 of JAG1 were
used to establish ﬁve distinct JAG1 knockout clonal lines from the parental
D3H2LN line (D3-P), named D3J1KO clonal lines 1-5. The sgRNA names refer to
position on Exon2. Homozygous frameshift mutations were conﬁrmed via next
generation amplicon sequencing (Illumina miniSeq 2x150). (B) Rescue of JAG1
expression was performed in D3J1KO Clone 1 using lentiviral (LV) methods.

Figure 3: JAG1 Promotes TNBC Lung Metastasis and Extravasation
A

B
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Figure 3. (A) Quantiﬁcation imaging results shows JAG1 positive cells extravasate at a higher rate than knockout cells six hours after IV
injection. n = each individual cell; 2 = extravasated; 1 = in-process; 0 = intravascular. (B) The extravasation frequency of cells is calculated
by taking the number of extravasated and in-process and dividing it by the total. Each point constitutes the average extravasation per
mouse. n = each mouse (fraction of in-process and extravasated cells). Error bars = SEM. * = p<0.05; ** = p<0.01; *** = p<0.001; **** =
p<0.0001. (C) Representative 3D confocal-rendered reconstruction of intravascular and extravasated cells in the lung 6 hours after
400,000 D3-P, D3J1KO C-1 RFPLV, or D3J1KO C-1 JAG1LV cells were injected intravenously into NCG mice.
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CONCLUSIONS
● JAG1 acts as a signaler to permit and promote
extravasation and metastasis of cancer cells
● JAG1 expression higher in patient breast cancer cells that
metastasize to LN compared to matched primary tumors
● Primary tumor samples have higher JAG1 signals in
aggressive clinical cases
● JAG1 promotes extravasation of TNBC Cells across lung
microvasculature in vivo

OUTLOOK
● Future Experiments
○ Additional TNBC cell lines will be utilized
● Future Studies
○ Track lung metastasis in orthotopic models
○ Long term eﬀects of tumor derived JAG1
■ Understand the consequences of JAG1
mediated extravasation on metastatic burden
and survival
○ Assess proprietary JAG1-blocking agents
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